Self · REGENERON PHARMACEUTICALS, INC. · Regeneron Pharmaceuticals, Inc. - Common Stock
Side
SELL
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
May 15, 2026
Disclosed
Jun 8, 2026
Disclosure timeline24 days from execution to publication · legal deadline 45 days
May 15 executedJun 8, 2026 disclosed
REGN · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 24 days after execution (STOCK Act deadline: 45)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.
Low: $1,001
High: $15,000
= $8,001
What this establishes
Gilbert Ray Cisneros, Jr. reported a sale of Regeneron Pharmaceuticals, Inc. - Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.
Extraction
Method
PDF text extraction
Confidence
1.00
Self
Gilbert Ray Cisneros, Jr.bioguide:C001123
Issuer
REGENERON PHARMACEUTICALS, INC.cik:0000872589
Revision history · 0
No field has changed since this record was first ingested.
